Kashiwagi Ryosuke, Ishida Masaharu, Onodera Koichi, Aoki Shuichi, Iseki Masahiro, Miura Takayuki, Ohtsuka Hideo, Mizuma Masamichi, Nakagawa Kei, Kamei Takashi, Unno Michiaki
Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, Miyagi, 980-8574, Japan.
Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Surg Case Rep. 2024 May 3;10(1):110. doi: 10.1186/s40792-024-01884-z.
Splenectomy is indicated in cases of autoimmune hemolytic anemia (AIHA), which are refractory to medical management. In post-splenectomy, there exists a theoretical risk of AIHA recurrence, especially if an accessory spleen undergoes compensatory hypertrophy. In this context, we present a unique case of recurrent AIHA managed through laparoscopic excision of the accessory spleen (LEAS).
A 60-year-old male underwent laparoscopic splenectomy (LS) for AIHA refractory to standard medical therapies. Following the surgery, there was a marked improvement in hemolytic anemia symptoms, and oral steroid therapy was terminated 7 months post-LS. Nonetheless, a year after the LS, the patient exhibited a marked decline in hemoglobin levels, dropping to a concerning 5.8 g/dl, necessitating the reintroduction of oral steroids. A subsequent contrast-enhanced computed tomography (CT) scan unveiled an enlarged accessory spleen. The patient then underwent LEAS, during which the accessory spleen, obscured within adipose tissue, proved challenging to visualize laparoscopically. This obstacle was surmounted utilizing intraoperative ultrasonography (US), enabling successful excision of the accessory spleen. The post-surgical period progressed without complications, and the steroid dosage was reduced to one-twelfth of its initial preoperative quantity.
Recurrent AIHA can be instigated by post-splenectomy compensatory hypertrophy of the accessory spleen. Ensuring comprehensive splenic tissue excision is crucial in AIHA management to obviate recurrent stemming from hypertrophic remnants. In scenarios of AIHA recurrence tied to an enlarged accessory spleen, LEAS stands as a viable and effective therapeutic modality.
脾切除术适用于药物治疗无效的自身免疫性溶血性贫血(AIHA)病例。脾切除术后,存在AIHA复发的理论风险,尤其是当副脾发生代偿性肥大时。在此背景下,我们报告一例通过腹腔镜切除副脾(LEAS)治疗复发性AIHA的独特病例。
一名60岁男性因标准药物治疗无效的AIHA接受了腹腔镜脾切除术(LS)。手术后,溶血性贫血症状明显改善,LS术后7个月停用口服类固醇治疗。尽管如此,LS术后一年,患者血红蛋白水平显著下降,降至令人担忧的5.8g/dl,需要重新开始口服类固醇治疗。随后的增强计算机断层扫描(CT)显示副脾肿大。患者随后接受了LEAS,术中发现副脾被脂肪组织包裹,腹腔镜下难以看清。通过术中超声检查(US)克服了这一障碍,成功切除了副脾。术后恢复顺利,无并发症,类固醇剂量减至术前初始剂量的十二分之一。
脾切除术后副脾代偿性肥大可引发复发性AIHA。在AIHA治疗中,确保彻底切除脾组织对于避免因肥大残余组织导致复发至关重要。在与肿大副脾相关的AIHA复发情况下,LEAS是一种可行且有效的治疗方式。